Toggle navigation
Home
Search
Services
Blog
Contact
About
Broad Spectrum RNAi Antiviral against Hemorrhagic Fever Virus
Alnylam Pharmaceuticals, Cambridge, MA, United States
Search grants from Alnylam Pharmaceuticals
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
ERK mediated control of Dicer and Drosha in C. elegans
Randomized Trial of a Self-Management Early Intervention for Combat-Related PTSD
In Vivo Pathogenesis of Helicobacter Pylori
Detailed Clinical Observations and Clinical Laboratory Correlations
Heme Protein Structure and Dynamics
Recently added grants:
CPRC Resources
Translational Science Initiative
Design and Development of Ligand-ResponsiveCRISPR-Cas Enzymes
Probing Respiration and Metabolism of a Periodontal Pathogen
Cardiovascular Surgery Training Program
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI60012-2-0-1
Application #
7699990
Study Section
Project Start
2006-09-29
Project End
2010-09-28
Budget Start
Budget End
Support Year
Fiscal Year
2008
Total Cost
$7,547,998
Indirect Cost
Institution
Name
Alnylam Pharmaceuticals
Department
Type
DUNS #
115524410
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Comments
Be the first to comment on this grant